bullish
Sinopharm (1099 HK): Top Distributor of Pharma Products in China
92 Views24 May 2018 18:20
Cheap on a gross profit basis, slow asset growth, and high level of cash sales relative to its sector
Sinopharm is the top distributor of pharma...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
Rising
A. Stotz Investment Research
Quantamental Investing to beat Benchmarks
- Sinopharm (国医控股) Placement - Unattractive but Inexpensive16 Jan 2020
- Sinopharm (1099 HK): Top Distributor of Pharma Products in China24 May 2018
- Initiating Coverage of Sinopharm with Narrow Moat Rating, FVE of HKD 36 Per Share03 May 2018
- Walgreens Invests in Sinopharm Retail Arm03 Dec 2017
- SINOPHARM (1099 HK): Not What It Seems27 Sep 2017
x